Clinical Cancer Research, Vol 4, Issue 7 1773-1778, Copyright © 1998 by American Association for Cancer Research

ARTICLES

Mutagen sensitivity to benzo(a)pyrene diol epoxide and the risk of squamous cell carcinoma of the head and neck

LE Wang, EM Sturgis, SA Eicher, MR Spitz, WK Hong and Q Wei
Department of Epidemiology, The University of Texas M.D. Anderson Cancer Center, Houston 77030, USA.

Genetic susceptibility appears to modulate an individual's risk of tobacco-induced carcinoma. One biomarker of such susceptibility, chromatid breaks induced in vitro in lymphocytes by the mutagen bleomycin, is an independent risk factor for several malignancies. To date, the more etiologically appropriate mutagen benzo(a)pyrene diol epoxide (BPDE) has only been used in one lung cancer study. Our objective was to evaluate the association between the BPDE-induced chromatid breaks per cell (b/c) values and the risk of squamous cell carcinoma of the head and neck (SCCHN) in a pilot case-control study. Blood samples were obtained from 60 SCCHN patients and 112 healthy controls matched for age, sex, ethnicity, and smoking status. After incubation and exposure to BPDE, metaphase spread slides were created, and the average b/c values were determined. Univariate analysis identified elevated BPDE-induced b/c values as a significant risk factor [P < 0.05, crude odds ratio (OR)=1.94, 95% confidence interval (CI)=1.00-3.74]. On multivariate analysis using logistic regression models and including age, sex, ethnicity, and smoking status, BPDE-induced b/c values remained an independent risk factor for disease (P < 0.05, adjusted OR=2.36, 95% CI=1.17-4.79). Furthermore, when b/c values were divided based on control values into low, medium, and high tertiles, there was a dose-response relationship: an adjusted OR of 1.28 (95% CI=0.49-3.33) for the middle tertile and an adjusted OR of 4.09 (95% CI=1.67-10.0) for the high tertile (trend test, P < 0.001). These findings suggest that high BPDE-induced b/c values in lymphocytes are an independent risk factor for SCCHN and a marker for genetic susceptibility to tobacco-induced carcinogenesis.

This article has been cited by other articles:

				L.-E Wang, P. Xiong, H. Zhao, M. R. Spitz, E. M. Sturgis, and Q. Wei Chromosome Instability and Risk of Squamous Cell Carcinomas of Head and Neck Cancer Res., June 1, 2008; 68(11): 4479 - 4485. [Abstract] [Full Text] [PDF]

				T. G. Natarajan, N. Ganesan, P. Carter-Nolan, C. A. Tucker, P. G. Shields, and L. L. Adams-Campbell {gamma}-Radiation-Induced Chromosomal Mutagen Sensitivity Is Associated with Breast Cancer Risk in African-American Women: Caffeine Modulates the Outcome of Mutagen Sensitivity Assay. Cancer Epidemiol. Biomarkers Prev., March 1, 2006; 15(3): 437 - 442. [Abstract] [Full Text] [PDF]

				L.-E Wang, P. Xiong, S. S. Strom, L. H. Goldberg, J. E. Lee, M. I. Ross, P. F. Mansfield, J. E. Gershenwald, V. G. Prieto, J. N. Cormier, et al. In Vitro Sensitivity to Ultraviolet B Light and Skin Cancer Risk: A Case-Control Analysis J Natl Cancer Inst, December 21, 2005; 97(24): 1822 - 1831. [Abstract] [Full Text] [PDF]

				E. M. Sturgis, K. R. Dahlstrom, M. R. Spitz, and Q. Wei DNA Repair Gene ERCC1 and ERCC2/XPD Polymorphisms and Risk of Squamous Cell Carcinoma of the Head and Neck Arch Otolaryngol Head Neck Surg, September 1, 2002; 128(9): 1084 - 1088. [Abstract] [Full Text] [PDF]

				P. Xiong, M. L. Bondy, D. Li, H. Shen, L.-E Wang, S. E. Singletary, M. R. Spitz, and Q. Wei Sensitivity to Benzo(a)pyrene Diol-Epoxide Associated with Risk of Breast Cancer in Young Women and Modulation by Glutathione S-Transferase Polymorphisms: A Case-Control Study Cancer Res., December 1, 2001; 61(23): 8465 - 8469. [Abstract] [Full Text] [PDF]

				M. L. Bondy, L.-E. Wang, R. El-Zein, M. de Andrade, M. S. Selvan, J. M. Bruner, V. A. Levin, W. K. Alfred Yung, P. Adatto, and Q. Wei {gamma}-Radiation Sensitivity and Risk of Glioma J Natl Cancer Inst, October 17, 2001; 93(20): 1553 - 1557. [Abstract] [Full Text] [PDF]

				M. Berwick and P. Vineis Markers of DNA Repair and Susceptibility to Cancer in Humans: an Epidemiologic Review J Natl Cancer Inst, June 7, 2000; 92(11): 874 - 897. [Abstract] [Full Text] [PDF]

				E. M. Sturgis, E. J. Castillo, L. Li, R. Zheng, S. A. Eicher, G. L. Clayman, S. S. Strom, M. R. Spitz, and Q. Wei Polymorphisms of DNA repair gene XRCC1 in squamous cell carcinoma of the head and neck Carcinogenesis, November 1, 1999; 20(11): 2125 - 2129. [Abstract] [Full Text] [PDF]

				N. Caporaso Genetics of Smoking-Related Cancer and Mutagen Sensitivity J Natl Cancer Inst, July 7, 1999; 91(13): 1097 - 1098. [Full Text] [PDF]

				E. M. Sturgis, G. L. Clayman, Y. Guan, Z. Guo, and Q. Wei DNA Repair in Lymphoblastoid Cell Lines From Patients With Head and Neck Cancer Arch Otolaryngol Head Neck Surg, February 1, 1999; 125(2): 185 - 190. [Abstract] [Full Text] [PDF]